PA Faculty Publications

Permanent URI for this collection


Recent Submissions

Now showing 1 - 5 of 33
  • Item
    Strategies for improving mental health in physician assistant students
    (Lippincott Williams and Wilkins, 2023-06-01) Wallace, Michelle
    [No abstract available]
  • Item
    A review of inherited cancer susceptibility syndromes
    (Wolters Kluwer Health, Inc., 2020-12) Brown, Gina; Simon, Madeline; Wentling, Chris; Spencer, Danielle M.; Parker, Ashley N.; Rogers, Corey A.
    Inherited cancer syndromes are caused by genetic mutations that place patients at an increased risk for developing cancer. Although most cancers are not caused by genetic inheritance, clinicians must understand these syndromes and be able to recognize their common characteristics. A thorough family history and identification of common patterns as well as specific clinical signs and symptoms can help with early recognition. This article describes symptoms of the more common cancer syndromes, including hereditary breast and ovarian cancer, Li-Fraumeni, Lynch, familial adenomatous polyposis, retinoblastoma, multiple endocrine neoplasia, and von Hippel-Lindau. Important patient education regarding genetic testing also is covered.
  • Item
    Methemoglobinemia in a 14-year-old girl with new-onset dyspnea
    (NLM (Medline), 2019-12-01) Wallace, Michelle; Tenbarge, Caitlin; Harlow, Sofia; Kasting, Nathan; Gooden, Justin
    Methemoglobinemia is a rare and potentially life-threatening medical emergency that can be overlooked when evaluating a patient in respiratory distress. Without early recognition, patients may develop respiratory failure and die. This article describes a teenager who presented to the ED for dyspnea and lightheadedness and failed to respond to supplemental oxygen. She was eventually diagnosed with methemoglobinemia.
  • Item
    Pharmacist involvement in trauma resuscitation across the United States: A 10-year follow-up survey
    (Oxford University Press, 2019-08-01) Porter, Blake A.; Zaeem, Maryam; Hewes, Philip D.; Hale, LaDonna S.; Jones, Courtney Marie Cora; Gestring, Mark L.; Acquisto, Nicole M.
    PURPOSE: A national survey performed in 2007 found that only 23% of American College of Surgeons (ACS) trauma centers involved pharmacists in trauma resuscitation. This study describes interval change in use, perceptions, and responsibilities from 2007 to 2017. METHODS: Of the 419 trauma centers identified from the ACS website, contact information was available for 335. In March 2017, a survey assessing hospital demographics, pharmacist coverage and services, and perception of pharmacist value and use was emailed to the identified trauma representatives. Data were analyzed using descriptive statistics and chi-square analysis, as appropriate. RESULTS: The response rate was 33% (110/335). Pharmacist involvement with trauma resuscitation increased significantly from 23% in 2007 to 70% (p < 0.001) and in 71% of trauma centers was provided by pharmacists practicing within the emergency department. Pharmacist involvement was greatest in the Midwest (p < 0.01), but with similar distribution with regards to ACS designation, institution type, and patient volume. Common bedside responsibilities include calculating dosages (96%), preparing medications (89%), and providing medication information (79%), while trauma program/administrative responsibilities (45%) include trauma team education, pharmacy operations, medication safety, quality improvement data collection, research, review of quality assurance cases, ACS accreditation preparation, and others. The primary reason for not considering pharmacist involvement was unfamiliarity with these roles/benefits. CONCLUSION: Pharmacists are an increasingly important component of the trauma team, as evidenced by growth over the last decade. In addition to clinical benefit at the bedside, pharmacists can support the regular activities of a trauma program in many meaningful ways.
  • Item
    When you hear hooves, do not ignore the zebra: malignancy disguised as recurrent pneumonia
    (American Thoracic Society, 2018-05-01) Mendoza, C. Ba; Sherman, Matthew; Fidahussein, S.
    Introduction: We present a case in which a rare malignancy is consistently misdiagnosed as a pneumonia and treated with antibiotic therapy over a span of three months before a diagnosis of extensive brochoalveolar carcinoma (adenocarcinoma in situ) was made.